This inventor holds 1 USPTO granted patent. Top assignee: Teva Pharmaceutical Industries Limited. Active years: 1991.
Company Filing History:
Years Active: 1991
Title: Zeev Mazor: Innovator in Renal Treatment
Introduction
Zeev Mazor is a notable inventor based in French Hill, IL. He has made significant contributions to the field of medicine, particularly in the treatment of renal osteodystrophy. His innovative approach has led to the development of a unique patent that addresses critical health issues.
Latest Patents
Zeev Mazor holds a patent for a method and composition aimed at improving the treatment of human renal osteodystrophy. This patent, which is titled "Combination of cholecalciferol derivatives for the treatment of renal," involves the administration of 6-40 mcg/d of 24,25(OH)₂D₃ in combination with 1-alpha(OH)D₃ or 1,25(OH)₂D₃ or DHT₂. The goal is to maintain serum calcium concentrations at 10-11 mg/dl and phosphate concentrations at 5.5-6.0 mg/dl, ensuring that the numerical multiplication product of calcium and phosphate does not exceed 60-65.
Career Highlights
Zeev Mazor has dedicated his career to advancing medical treatments through innovative research and development. His work at Teva Pharmaceutical Industries Limited has positioned him as a key player in the pharmaceutical industry. His patent reflects his commitment to improving patient outcomes and addressing complex health challenges.
Collaborations
Throughout his career, Zeev has collaborated with esteemed colleagues such as Shmuel Edelstein and David Ladkani. These partnerships have fostered an environment of innovation and have contributed to the success of his projects.
Conclusion
Zeev Mazor's contributions to the field of renal treatment through his innovative patent demonstrate his dedication to improving healthcare. His work continues to impact the lives of patients suffering from renal osteodystrophy, showcasing the importance of innovation in medicine.